BRIEF-U.S. FDA expands approved use of Stivarga to treat liver cancer
* The FDA granted the approval of Stivarga to Bayer Healthcare Pharmaceuticals Inc Source text (http://bit.ly/2pDo2pY) Further company coverage:
April 6 Kyowa Hakko Kirin Co Ltd:
* Kyowa Hakko Kirin Co Ltd -announced global phase 3 study of mogamulizumab in patients with cutaneous t-cell lymphoma met its primary endpoint
* Kyowa Hakko Kirin Co Ltd -plans to initiate discussions with global regulatory authorities in 2017 Source text:(bit.ly/2p7esaz) Further company coverage:
TORONTO, April 27 Exiger, a firm that helps businesses monitor compliances such as money laundering regulations, has agreed to buy OutsideIQ, a Canadian startup that specializes in technology that helps businesses assess and manage risk.
SAO PAULO/RIO DE JANEIRO, April 27 Shares in Vale SA slumped the most in two weeks on Thursday, as executives signaled lackluster trends for iron ore prices this year and investors reacted to a first-quarter profit miss with disappointment.